260 related articles for article (PubMed ID: 32757093)
1. Nanoparticles as immunomodulators and translational agents in brain tumors.
Grippin AJ; Dyson KA; Qdaisat S; McGuiness J; Wummer B; Mitchell DA; Mendez-Gomez HR; Sayour EJ
J Neurooncol; 2021 Jan; 151(1):29-39. PubMed ID: 32757093
[TBL] [Abstract][Full Text] [Related]
2. In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma.
Wang X; Ye L; He W; Teng C; Sun S; Lu H; Li S; Lv L; Cao X; Yin H; Lv W; Xin H
J Control Release; 2022 May; 345():786-797. PubMed ID: 35367277
[TBL] [Abstract][Full Text] [Related]
3. Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances.
Ganjeifar B; Morshed SF
Curr Top Med Chem; 2021 Oct; 21(14):1202-1223. PubMed ID: 33185163
[TBL] [Abstract][Full Text] [Related]
4. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
5. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
6. Dynamic immuno-nanomedicines in oncology.
Ling H; Zhang Q; Luo Q; Ouyang D; He Z; Sun J; Sun M
J Control Release; 2024 Jan; 365():668-687. PubMed ID: 38042376
[TBL] [Abstract][Full Text] [Related]
7. Biomaterial-based technologies for brain anti-cancer therapeutics and imaging.
Orive G; Ali OA; Anitua E; Pedraz JL; Emerich DF
Biochim Biophys Acta; 2010 Aug; 1806(1):96-107. PubMed ID: 20406668
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
9. New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.
Doolittle ND; Abrey LE; Bleyer WA; Brem S; Davis TP; Dore-Duffy P; Drewes LR; Hall WA; Hoffman JM; Korfel A; Martuza R; Muldoon LL; Peereboom D; Peterson DR; Rabkin SD; Smith Q; Stevens GH; Neuwelt EA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):421-8. PubMed ID: 15701824
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles for brain tumor imaging and therapy.
Cheng Y; Morshed RA; Auffinger B; Tobias AL; Lesniak MS
Adv Drug Deliv Rev; 2014 Feb; 66():42-57. PubMed ID: 24060923
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment.
Raudino G; Caffo M; Caruso G; Alafaci C; Tomasello F
Recent Pat Nanotechnol; 2011 Nov; 5(3):239-44. PubMed ID: 21871014
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
13. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
14. Delivery of Nanoparticles for Treatment of Brain Tumor.
Kang C; Sun Y; Zhu J; Li W; Zhang A; Kuang T; Xie J; Yang Z
Curr Drug Metab; 2016; 17(8):745-754. PubMed ID: 27469219
[TBL] [Abstract][Full Text] [Related]
15. Novel technologies for antiangiogenic drug delivery in the brain.
Benny O; Pakneshan P
Cell Adh Migr; 2009; 3(2):224-9. PubMed ID: 19262168
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J
ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254
[TBL] [Abstract][Full Text] [Related]
18. The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.
Kim C; Lim M; Woodworth GF; Arvanitis CD
J Neurooncol; 2022 Apr; 157(2):221-236. PubMed ID: 35235137
[TBL] [Abstract][Full Text] [Related]
19. Nanotherapeutic approaches for brain cancer management.
Saenz del Burgo L; Hernández RM; Orive G; Pedraz JL
Nanomedicine; 2014 Jul; 10(5):905-19. PubMed ID: 24135564
[TBL] [Abstract][Full Text] [Related]
20. Nanobiotechnology-based delivery strategies: New frontiers in brain tumor targeted therapies.
Mangraviti A; Gullotti D; Tyler B; Brem H
J Control Release; 2016 Oct; 240():443-453. PubMed ID: 27016141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
